Does LOBAPLATIN Cause Off label use? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Off label use have been filed in association with LOBAPLATIN. This represents 7.5% of all adverse event reports for LOBAPLATIN.
15
Reports of Off label use with LOBAPLATIN
7.5%
of all LOBAPLATIN reports
1
Deaths
8
Hospitalizations
How Dangerous Is Off label use From LOBAPLATIN?
Of the 15 reports, 1 (6.7%) resulted in death, 8 (53.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOBAPLATIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does LOBAPLATIN Cause?
Myelosuppression (84)
White blood cell count decreased (21)
Platelet count decreased (17)
Nausea (14)
Neutrophil count decreased (14)
Bone marrow failure (12)
Vomiting (11)
Hepatic function abnormal (10)
Rash (10)
Asthenia (9)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LOBAPLATIN Alternatives Have Lower Off label use Risk?
LOBAPLATIN vs LOFEXIDINE
LOBAPLATIN vs LOMITAPIDE
LOBAPLATIN vs LOMUSTINE
LOBAPLATIN vs LONAPEGSOMATROPIN-TCGD
LOBAPLATIN vs LONCASTUXIMAB TESIRINE-LPYL